HFA Premium Access

Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

Congress Presentation

About the speaker

Doctor Yury Mareev

Rambam Health Care Campus, Haifa (Israel)
0 follower

9 more presentations in this session

Heart failure with preserved ejection fraction: does the intra-venous diuretic treatment duration matter?

Speaker: Doctor J. Ribeiro (Porto, PT)


Blood purification in end-stage heart failure: a study in 16 patients


What are predictive factors for body weight loss in patients with acute decompensated heart failure added an oral aquaretic, tolvaptan ?

Speaker: Doctor T. Ando (Hyogo, JP)


Discontinuation of diuretic therapy is safe in accurately selected patients with chronic heart failure and severely reduced ejection fraction: a prospective cohort study in the outpatients setting

Speaker: Doctor C. Mina (Palermo, IT)


Influence of clinical severity on the association of loop diuretic dose with mortality in patients with heart failure: insights from the unite-hf registry

Speaker: Doctor K. Adams Jr (Chapel Hill, US)


Access the full session

Poster Session 3 - Diuretics and fluid status management

Speakers: Doctor Y. Mareev, Doctor J. Ribeiro, Doctor T. Ando, Doctor C. Mina, Doctor K. Adams Jr

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb